ArticleBMC cancer2023

A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China.

Shuling Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.